Form 4: Coherus BioSciences CFO Bryan J. McMichael Acquires 200,000 Stock Options

Sentiment:

SEC Form 4 Filing


Bryan J. McMichael, CFO of Coherus BioSciences, acquired 200,000 stock options on May 7, 2025, according to a Form 4 filing with the SEC.

Summary

  • On May 7, 2025, Bryan J. McMichael, the Chief Financial Officer of Coherus BioSciences, Inc. [CHRS], acquired 200,000 stock options.
  • These options have an exercise price of $0.9462.
  • The options vest in installments, starting with 1/4th of the total shares vesting on May 7, 2026, and the remaining shares vesting monthly thereafter, contingent upon continued service with the company.
  • The options expire on May 7, 2035.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to stock option grants, which is a neutral event. It doesn't inherently indicate positive or negative sentiment, but rather a standard part of executive compensation.

Industry Context

This is a standard practice for companies to grant stock options to executives as part of their compensation packages, aligning their interests with those of the shareholders.

Stakeholder Impact

  • The granting of stock options can incentivize management to improve company performance, potentially benefiting shareholders.
  • Employees may view stock option grants to executives as a positive sign of company growth and stability.

Key Dates

DateDescription
05/07/2025Date of transaction: CFO Bryan J. McMichael acquired 200,000 stock options.
05/07/2026First vesting date: 1/4th of the total shares subject to the option vest.
05/07/2035Expiration date of the stock options.
05/09/2025Date of signature on the Form 4 filing.

Keywords

stock options, Form 4, Coherus BioSciences, Bryan J. McMichael, CFO, acquisition, vesting, CHRS

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.